21 Jan 2016
Reply
Enquiry//Development quantities of Miglustat needed for Iran [EN00239]
A manufacturing company in Iran is looking for R&D quantities of Miglustat API for generic drug development. With almost USD 100 million in annual sales, Miglustat is the API for Actelion’s product Zavesca. https://www.pharmacompass.com/active-pharmaceutical-ingredients/miglustat
bareket.gelbhart@dipharma.ch
we are able to supply capsules. please contact us at:
Bareket.gelbhart@dipharma.ch
22:11, 11 Feb 2016
drmni@adroitpharmachem.com
We can supply you this product for R & D and then commercial purpose. Pl contact us
01:49, 18 Mar 2016
akshit@zenithhealthcare.com
Please email your requirements on akshit@zenithhealthcare.com
18:41, 03 Apr 2016
sam.d@micoson.com
We want to know whether you are still paying attention to Miglustat. We'd like to discuss it further. Please send an email to sam.d@micoson.com.
Thank you.
20:58, 04 Mar 2023
